STOCK TITAN

T. Rowe Price reports 5.5% stake in StoneX

T. Rowe Price Associates, Inc. filed a Schedule 13G reporting beneficial ownership of 2,851,483 shares of StoneX Group Inc. common stock, representing 5.5% of the class as of 12/31/2025.

Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

T. Rowe Price Associates, Inc. filed a Schedule 13G reporting beneficial ownership of 2,851,483 shares of StoneX Group Inc. common stock, representing 5.5% of the class as of 12/31/2025. T. Rowe Price reports sole voting power over 2,812,135 shares and sole dispositive power over 2,851,468 shares, with no shared voting or dispositive power.

The firm states the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of StoneX Group. The filing also notes that T. Rowe Price Associates expressly denies being the beneficial owner of the securities referred to, despite reporting them for Schedule 13G purposes.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does T. Rowe Price Associates’ Schedule 13G filing for SNEX report?

T. Rowe Price Associates reports beneficial ownership of 2,851,483 StoneX Group (SNEX) common shares, or 5.5% of the class. The position is reported on a passive Schedule 13G, indicating holdings in the ordinary course of its investment advisory business.

How large is T. Rowe Price Associates’ ownership stake in StoneX Group (SNEX)?

T. Rowe Price Associates reports owning 2,851,483 StoneX Group shares, representing 5.5% of the common stock. This crosses the 5% threshold that requires public disclosure on Schedule 13G under U.S. securities laws for institutional investment advisers.

Does T. Rowe Price have voting and dispositive power over its SNEX shares?

The filing shows sole voting power over 2,812,135 StoneX Group shares and sole dispositive power over 2,851,468 shares. It reports no shared voting or shared dispositive power, indicating T. Rowe Price alone directs votes and investment decisions for these reported holdings.

Is T. Rowe Price Associates’ SNEX position intended to influence control of the company?

No. T. Rowe Price certifies the StoneX Group shares were acquired and are held in the ordinary course of business. It states they were not acquired to change or influence control of StoneX, consistent with a passive Schedule 13G filing status.

What type of reporting person is T. Rowe Price in this SNEX Schedule 13G?

T. Rowe Price Associates is identified as a Maryland entity and an investment adviser qualifying under Rule 13d-1(b)(1)(ii)(E). This classification covers institutional advisers that report beneficial ownership positions exceeding 5% on a Schedule 13G instead of a Schedule 13D.

On what date was T. Rowe Price’s SNEX ownership measured for this Schedule 13G?

The ownership information is reported as of December 31, 2025, which is the event date triggering the Schedule 13G. At that date, T. Rowe Price’s beneficial ownership in StoneX Group reached the disclosed 2,851,483 shares, or 5.5% of the outstanding common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Associates, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:02/17/2026

Keep reading